ArticleTransportation research interdisciplinary perspectives2022
Spatiotemporal analysis of urban road congestion during and post COVID-19 pandemic in Shanghai, China.
Article in Transportation research interdisciplinary perspectives, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Hybrid deep learning techniques for adaptive routing and congestion control in urban VANET for wireless mobile networking.Scientific reports · 2026Article
- The impact of COVID-19 vaccination rate on traffic recovery.Scientific reports · 2024Article
- Estimating pandemic effects in urban mass transportation systems: An approach based on visibility graphs and network similarity.Physica A · 2023Article
- The job of public transport, ride-hailing and delivery drivers: Conditions during the COVID-19 pandemic and implications for a post-pandemic future.Travel behaviour & society · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coronavirus Disease 2019 (COVID-19) has become one of the most serious global health crises in decades and tremendously influence the human mobility. Many residents changed their travel behavior during and after the pandemic, especially for a certain percentage of public transport users who chose to drive their owned vehicles. Thus, urban roadway congestion has been getting worse, and the spatiotemporal congestion patterns has changed significantly. Understanding spatiotemporal heterogeneity of urban roadway congestion during and post the pandemic is essential for mobility management. In this study, an analytical framework was proposed to investigate the spatiotemporal heterogeneity of urban roadway congestion in Shanghai, China. First, the matrix of average speed in each traffic analysis zones (TAZs) was calculated to extract spatiotemporal heterogeneity variation features. Second, the heterogenous component of each TAZ was extracted from the overall traffic characteristics using robust principal component analysis (RPCA). Third, clustering analysis was employed to explain the spatiotemporal distribution of heterogeneous traffic characteristics. Finally, fluctuation features of these characteristics were analyzed by iterated cumulative sums of squares (ICSS). The case study results suggested that the urban road traffic state evolution was complicated and varied significantly in different zones and periods during the long-term pandemic. Compared with suburban areas, traffic conditions in city central areas are more susceptible to the pandemic and other events. In some areas, the heterogeneous component shows opposite characteristics on working days and holidays with others. The key time nodes of state change for different areas have commonness and individuality. The proposed analytical framework and empirical results contribute to the policy decision-making of urban road transportation system during and post the COVID-19 pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.